Abstract
Serial isolates of Mycobacterium tuberculosis were cultured from a patient who failed to respond to standard antituberculous chemotherapy. Isolates were cultured in March 1989, July 1989, December 1989 and May 1990. Each successive isolate was found to be resistant to a wider range of antituberculous drugs than its predecessors. The initial isolate was resistant to isoniazid and rifampin, the second isolate was also resistant to ethambutol, the third was also resistant to pyrazinamide, ansamycin (= rifabutin) and ofloxacin and the last isolate was also resistant to ciprofloxacin and sparfloxacin. All four isolates' bacteriophage typing profiles and DNA restriction fragment patterns determined by Southern blot hybridization using the IS6110/IS986 probes and the new probe pTBN12 were concordant. It was concluded that this patient was persistently infected with a single strain of Mycobacterium tuberculosis which developed resistance to a number of families of drugs but did not show any significant change in typing patterns. The problem of acquired multiple drug resistance, particularly to fluoroquinolones and rifamycins, represents a new challenge in tuberculosis therapy.
MeSH Terms
Adult
Anti-Bacterial Agents/pharmacology,therapeutic use
Anti-Infective Agents/pharmacology,therapeutic use
Antibiotics, Antitubercular/pharmacology,therapeutic use
Antitubercular Agents/pharmacology,therapeutic use
Bacteriophage Typing
Blotting, Southern
Clofazimine/pharmacology,therapeutic use
Colony Count, Microbial
DNA, Bacterial/genetics
Drug Resistance, Microbial/genetics
Fluoroquinolones
Humans
Isoniazid/pharmacology,therapeutic use
Lactams, Macrocyclic
Male
Microbial Sensitivity Tests
Mycobacterium tuberculosis/classification,drug effects,genetics
Polymorphism, Restriction Fragment Length
Rifamycins/pharmacology,therapeutic use
Tuberculosis, Pulmonary/drug therapy,microbiology
Chemicals
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antitubercular Agents
DNA, Bacterial
Fluoroquinolones
Lactams, Macrocyclic
Rifamycins
Clofazimine
Isoniazid
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Rastogi N
Unité de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris, France.
Ross B C
Dwyer B
Goh K S
Clavel-Sérès S
Jeantils V
Cruaud P
References (20)
20 references, click to expand
-
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.
Antimicrob Agents Chemother. 1991 Sep;35(9):1933-6
PMID: 1952872
-
Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis.
J Clin Microbiol. 1990 Sep;28(9):2051-8
PMID: 1977765
-
Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.
Am Rev Respir Dis. 1991 Oct;144(4):745-9
PMID: 1928942
-
Differentiation of Mycobacterium tuberculosis strains by use of a nonradioactive Southern blot hybridization method.
J Infect Dis. 1991 Apr;163(4):904-7
PMID: 1672703
-
Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis.
J Clin Microbiol. 1991 Sep;29(9):2030-3
PMID: 1663520
-
The U-shaped curve of concern.
Am Rev Respir Dis. 1991 Oct;144(4):741-2
PMID: 1928940
-
Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
Ann Inst Pasteur Microbiol. 1988 Mar-Apr;139(2):233-7
PMID: 3165641
-
[Distribution of bacteriophage types of Mycobacterium tuberculosis in France].
Rev Mal Respir. 1988;5(6):577-81
PMID: 3146114
-
Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis.
J Infect Dis. 1990 May;161(5):977-81
PMID: 2109022
-
Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients.
Lancet. 1991 Apr 6;337(8745):852
PMID: 1672939
-
Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire.
Am Rev Respir Dis. 1991 Oct;144(4):750-5
PMID: 1928943
-
Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool.
J Clin Microbiol. 1992 Apr;30(4):942-6
PMID: 1572981
-
Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis.
J Clin Microbiol. 1991 Jun;29(6):1252-4
PMID: 1677943
-
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.
J Clin Microbiol. 1981 May;13(5):908-12
PMID: 6787076
-
World Health Organization studies on bacteriophage typing of mycobacteria. Subdivision of the species Mycobacterium tuberculosis.
Am Rev Respir Dis. 1975 Apr;111(4):459-68
PMID: 804840
-
A strategic plan for the elimination of tuberculosis in the United States.
MMWR Suppl. 1989 Apr 21;38(3):1-25
PMID: 2495432
-
Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family.
Mol Microbiol. 1990 Sep;4(9):1607-13
PMID: 1981088
-
Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis.
J Clin Microbiol. 1990 Dec;28(12):2668-73
PMID: 2177747
-
[Distribution of lysotypes of Mycobacterium tuberculosis in relation to the country of origin of the patient].
Ann Microbiol (Paris). 1984 Jul-Aug;135B(1):35-44
PMID: 6439095
-
Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.
J Clin Microbiol. 1991 Nov;29(11):2578-86
PMID: 1685494